175 related articles for article (PubMed ID: 24349057)
1. Sperm associated antigen 9 plays an important role in bladder transitional cell carcinoma.
Kanojia D; Garg M; Saini S; Agarwal S; Parashar D; Jagadish N; Seth A; Bhatnagar A; Gupta A; Kumar R; Lohiya NK; Suri A
PLoS One; 2013; 8(12):e81348. PubMed ID: 24349057
[TBL] [Abstract][Full Text] [Related]
2. Sperm-associated antigen 9 is a novel biomarker for colorectal cancer and is involved in tumor growth and tumorigenicity.
Kanojia D; Garg M; Gupta S; Gupta A; Suri A
Am J Pathol; 2011 Mar; 178(3):1009-20. PubMed ID: 21356354
[TBL] [Abstract][Full Text] [Related]
3. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E
Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057
[TBL] [Abstract][Full Text] [Related]
4. Sperm associated antigen 9 (SPAG9) a promising therapeutic target of ovarian carcinoma.
Jagadish N; Fatima R; Sharma A; Devi S; Suri V; Kumar V; Suri A
Tumour Biol; 2018 May; 40(5):1010428318773652. PubMed ID: 29745297
[TBL] [Abstract][Full Text] [Related]
5. Sperm-associated antigen 9 (SPAG9) promotes the survival and tumor growth of triple-negative breast cancer cells.
Jagadish N; Gupta N; Agarwal S; Parashar D; Sharma A; Fatima R; Topno AP; Kumar V; Suri A
Tumour Biol; 2016 Oct; 37(10):13101-13110. PubMed ID: 27449044
[TBL] [Abstract][Full Text] [Related]
6. Down regulation of SPAG9 reduces growth and invasive potential of triple-negative breast cancer cells: possible implications in targeted therapy.
Sinha A; Agarwal S; Parashar D; Verma A; Saini S; Jagadish N; Ansari AS; Lohiya NK; Suri A
J Exp Clin Cancer Res; 2013 Sep; 32(1):69. PubMed ID: 24330581
[TBL] [Abstract][Full Text] [Related]
7. Sperm-associated antigen 9 is associated with tumor growth, migration, and invasion in renal cell carcinoma.
Garg M; Kanojia D; Khosla A; Dudha N; Sati S; Chaurasiya D; Jagadish N; Seth A; Kumar R; Gupta S; Gupta A; Lohiya NK; Suri A
Cancer Res; 2008 Oct; 68(20):8240-8. PubMed ID: 18922895
[TBL] [Abstract][Full Text] [Related]
8. FEZ1/LZTS1 is down-regulated in high-grade bladder cancer, and its restoration suppresses tumorigenicity in transitional cell carcinoma cells.
Vecchione A; Ishii H; Baldassarre G; Bassi P; Trapasso F; Alder H; Pagano F; Gomella LG; Croce CM; Baffa R
Am J Pathol; 2002 Apr; 160(4):1345-52. PubMed ID: 11943719
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-200a-3p suppresses tumor proliferation and induces apoptosis by targeting SPAG9 in renal cell carcinoma.
Wang X; Jiang F; Song H; Li X; Xian J; Gu X
Biochem Biophys Res Commun; 2016 Feb; 470(3):620-626. PubMed ID: 26797273
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle regulators in bladder cancer: relationship to schistosomiasis.
Eissa S; Ahmed MI; Said H; Zaghlool A; El-Ahmady O
IUBMB Life; 2004 Sep; 56(9):557-64. PubMed ID: 15590562
[TBL] [Abstract][Full Text] [Related]
11. Cholera toxin, a typical protein kinase A activator, induces G1 phase growth arrest in human bladder transitional cell carcinoma cells via inhibiting the c-Raf/MEK/ERK signaling pathway.
Zheng X; Ou Y; Shu M; Wang Y; Zhou Y; Su X; Zhu W; Yin W; Li S; Qiu P; Yan G; Zhang J; Hu J; Xu D
Mol Med Rep; 2014 May; 9(5):1773-9. PubMed ID: 24626525
[TBL] [Abstract][Full Text] [Related]
12. Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages.
Tyagi A; Agarwal C; Harrison G; Glode LM; Agarwal R
Carcinogenesis; 2004 Sep; 25(9):1711-20. PubMed ID: 15117815
[TBL] [Abstract][Full Text] [Related]
13.
Qiao L; Zhang L; Wang H
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107702
[TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
Kunze E; Wendt M; Schlott T
Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
[TBL] [Abstract][Full Text] [Related]
15. Sperm-associated antigen 9: a novel diagnostic marker for thyroid cancer.
Garg M; Kanojia D; Suri S; Gupta S; Gupta A; Suri A
J Clin Endocrinol Metab; 2009 Nov; 94(11):4613-8. PubMed ID: 19820019
[TBL] [Abstract][Full Text] [Related]
16. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
[TBL] [Abstract][Full Text] [Related]
17. SPAG9 is overexpressed in human prostate cancer and promotes cancer cell proliferation.
Li H; Peng Y; Niu H; Wu B; Zhang Y; Zhang Y; Bai X; He P
Tumour Biol; 2014 Jul; 35(7):6949-54. PubMed ID: 24740566
[TBL] [Abstract][Full Text] [Related]
18. Direct targeting sperm-associated antigen 9 by miR-141 influences hepatocellular carcinoma cell growth and metastasis via JNK pathway.
Lou G; Dong X; Xia C; Ye B; Yan Q; Wu S; Yu Y; Liu F; Zheng M; Chen Z; Liu Y
J Exp Clin Cancer Res; 2016 Jan; 35():14. PubMed ID: 26790956
[TBL] [Abstract][Full Text] [Related]
19. Urinary bladder transitional cell carcinogenesis is associated with down-regulation of NF1 tumor suppressor gene in vivo and in vitro.
Aaltonen V; Boström PJ; Söderström KO; Hirvonen O; Tuukkanen J; Nurmi M; Laato M; Peltonen J
Am J Pathol; 1999 Mar; 154(3):755-65. PubMed ID: 10079253
[TBL] [Abstract][Full Text] [Related]
20. Integrin alpha(v) and coxsackie adenovirus receptor expression in clinical bladder cancer.
Sachs MD; Rauen KA; Ramamurthy M; Dodson JL; De Marzo AM; Putzi MJ; Schoenberg MP; Rodriguez R
Urology; 2002 Sep; 60(3):531-6. PubMed ID: 12350512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
